Effect of sydnone SYD-1, a mesoionic compound, on energy-linked functions of rat liver mitochondria

Chemico-Biological Interactions

Volumn 169, Issue 3, 2007, Pages 160-170

  Halila, Gerusa Clazer ^a   de Oliveira, Maria Benigna Martinelli ^a   Echevarria, Aurea ^b   Belém, Alice Carneiro ^b   Rocha, Maria Eliane Merlin ^a   Carnieri, Eva Gunilla Skare ^a   Martinez, Glaucia Regina ^a   Noleto, Guilhermina Rodrigues ^a   Cadena, Silvia Maria Suter Correia ^a  

^a FEDERAL UNIVERSITY OF PARANÁ   (Brazil)

^b FEDERAL RURAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

Author keywords

Liver mitochondria; Mesoionic compound; Mitochondrial swelling; Mitochondrial transmembrane electrical potential; Respiratory chain enzymes; Sydnone

Indexed keywords

3 [4 CHLORO 3 NITROPHENYL] 1,2,3 OXADIAZOLIUM 5 OLATE; ADENOSINE TRIPHOSPHATASE; AMPHOLYTE; ANTIMYCIN A1; GLUTAMATE DEHYDROGENASE; GLUTAMATE SODIUM; POTASSIUM; ROTENONE; SUCCINIC ACID; SYD 1; SYDNONE DERIVATIVE; UNCLASSIFIED DRUG; VALINOMYCIN;

ANIMAL CELL; ANTINEOPLASTIC ACTIVITY; ARTICLE; BREATHING RATE; CONTROLLED STUDY; DRUG STRUCTURE; ELECTRIC POTENTIAL; ELECTRON TRANSPORT; ENZYME ACTIVITY; HYDROLYSIS; LIVER; LIVER MITOCHONDRION; MALE; MEMBRANE PERMEABILITY; MITOCHONDRIAL MEMBRANE; MITOCHONDRIAL RESPIRATION; MITOCHONDRION SWELLING; NONHUMAN; RAT;

ADENOSINE TRIPHOSPHATASES; ANIMALS; CELL MEMBRANE; CELL RESPIRATION; IONS; MALE; MEMBRANE POTENTIALS; MITOCHONDRIA, LIVER; MITOCHONDRIAL SWELLING; MOLECULAR STRUCTURE; OLIGOMYCINS; OXADIAZOLES; RATS; RATS, WISTAR; SYDNONES;

RATTUS;

EID: 34548316011     PISSN: 00092797     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cbi.2007.06.003     Document Type: Article

References (49)

1. Ollis W.D., and Ramsden C.A. Meso-ionic compounds. Adv. Heterocycl. Chem. 19 (1976) 1-121
2. Newton C.G., and Ramsden C.A. Meso-ionic heterocycles. Tetrahedron 38 (1982) 2965-3011
3. Satyanarayana K., and Rao M.N.A. Synthesis and antiinflammatory, analgesic and antipyretic testing of 4-[1-oxo-(3-substituted aryl)-2-propenyl]-3-phenylsydnones and 3-[4-(3-(substituted aryl)-1-oxo-2-propenyl) phenyl] sydnones. J. Pharm. Sci. 84 (1995) 263-266
4. Cardoso J.C., Cadena S.M.S.C., Zamproio A., Arruda A.M.S., Carnieri E.G.S., Echevarria A., Constantin J., Bracht A., and Oliveira M.B.M. Effects of a new 1,3,4-thiadiazolium mesoionic compound, MI-D, on the acute inflammatory response. Drug Dev. Res. 61 (2004) 207-217
5. Montanari C.A., Beezer A.E., Sandall J.P.B., Montanari M.C.L., Miller J., and Giesbrecht A.M. On the interaction of some mesoionic compounds with Saccharomyces cerivisiae by biological microcalorimetry. Rev. Microbiol. 23 (1992) 274-278
6. Corell T., Pedersen S.B., Lissau B., Moilanen E., Metsä-Ketelä T., Kankaanranta H., Vuorinen P., Vapaatalo H., Rydell E., Andersson R., Marcinkiewicz E., Korbut R., and Gryglewski R.J. Pharmacology of mesoionic oxatriazole derivatives in blood, cardiovascular and respiratory systems. Pol. J. Pharm. 46 (1994) 553-566
7. Grynberg N., Gomes R., Shinzato T., Echevarria A., and Miller J. Some new aryl-sydnones: effects on murine tumours. Anticancer Res. 12 (1992) 1025-1028
8. Grynberg N., Santos A.C., and Echevarria A. Synthesis and in vivo antitumor activity of new heterocyclic derivatives of the 1,3,4-thiadiazolium-2-aminide class. Anti-Cancer Drug 8 (1997) 88-91
9. Senff-Ribeiro A., Echevarria A., Silva E.F., Veiga S.S., and Oliveira M.B.M. Effects of a new 1,3,4-thiadiazolium mesoionic compound (MI-D) on B16-F10 murine melanoma. Melanoma Res. 13 (2003) 465-472
10. Senff-Ribeiro A., Echevarria A., Silva E.F., Veiga S.S., and Oliveira M.B.M. Antimelanoma activity of 1,3,4-thiadiazolium mesoionics: a structure-activity relationship study. Anti-Cancer Drugs 15 (2004) 269-275
11. Senff-Ribeiro A., Echevarria A., Silva E.F., Veiga S.S., and Oliveira M.B.M. Cytotoxic effect of a new 1,3,4-tiadiazolium mesoiônico compound (MI-D) on cell lines of human melanoma. Br. J. Cancer 91 (2004) 297-304
12. Cadena S.M.S.C., Carnieri E.G.S., Echevarria A., and Oliveira M.B.M. Effect of MI-D, a new mesoionic compound, on energy-linked functions of rat liver mitochondria. FEBS Lett. 440 (1998) 46-50
13. Cadena S.M.S.C., Carnieri E.G.S., Echevarria A., and Oliveira M.B.M. Interference of MI-D, a new mesoionic compound, on artificial and native membranes. Cell Biochem. Funct. 20 (2002) 31-37
14. Moustafa M.A.A., and Eisa H.M. Synthesis and antimicrobial activity of 3-(substituted-phenyl)-sydnones. Arch. Pharm. 325 (1992) 397-401
15. Dunkley C.S., and Thoman C.J. Synthesis and biological evaluation of a novel phenyl substituted sydnone series as potential antitumor agents. Bioorg. Med. Chem. Lett. 13 (2003) 2899-2901
16. Voss D.O., Campelo A.P., and Bacila M. The respiratory chain and the oxidative phosphorylation of rat brain mitochondria. Biochem. Biophys. Res. Commun. 4 (1961) 48-51
17. Mustafa M.G., Utsumi K., and Packer L. Damped oscillatory control of mitochondrial respiration and volume. Biochem. Biophys. Res. Commun. 24 (1966) 381-385
18. Voss D.O., Cowles J.C., and Bacila M.A. A new oxygen electrode model for the polarographic assay of cellular and mitochondrial respiration. Anal. Biochem. 6 (1963) 211-222
19. Chance B., and Williams G.R. The respiratory enzymes in oxidative phosphorylation. I. Kinetics of oxygen utilization. J. Biol. Chem. 217 (1955) 383-393
20. Estabrook R.W. Mitochondrial respiratory control and the polarographic measurement of ADP/O ratios. Method Enzymol. 10 (1967) 41-47
21. Akerman K.E.O., and Wikström M.F.K. Safranine as a probe of the mitochondrial membrane potential. FEBS Lett. 68 (1976) 191-197
22. Weickowski M.R., and Wojtczak L. Fatty acid-induced uncoupling of oxidative phosphorylation is partly due to opening of the mitochondrial permeability transition pore. FEBS Lett. 423 (1998) 339-342
23. + translocation. Eur. J. Biochem. 7 (1969) 418-426
24. Seppala A.J., Wikström M.K.F., and Saris N.E.L. Damping of mitochondrial volume oscillations by propanolol and related compounds. In: Chance B., Pye E.K., Ghoso A.K., and Hess B. (Eds). Biological and Biochemical Oscillators (1973), Academic Press, New York 115-124
25. Moreno J.M., and Madeira V.M.C. Interference of parathion with mitochondrial bioenergetics. Biochim. Biophys. Acta 1015 (1990) 361-367
26. Singer T.P. Determination of the activity of succinate, NADH, choline and α-glycerophosphate dehydrogenases. Methods Biochem. Anal. 22 (1974) 123-175
27. Somlo M. Induction des lactico-cytocrome c reductases (D-ET L-) de la levure aerobie par les lactates (D-ET-L). Biochim. Biophys. Acta 97 (1965) 183-201
28. Mason T.L., Poyton R.O., Wharton D.C., and Schatz G. Cytocrome c oxidase from bakers yeast, isolation and properties. J. Biol. Chem. 248 (1973) 1346-1354
29. Strecker H.J. l-Glutamic dehydrogenase from liver. Method Enzymol. 2 (1955) 220-225
30. Pullman M.E., Penefsky H.S., Datta A., and Racker E. Partial resolution of the enzymes catalysing oxidative phosphorylation. I. Purification and properties of soluble, dinitrophenol-stimulated adenosine triphosphatase. J. Biol. Chem. 235 (1960) 3322-3329
31. Sumner J.B. Scientific apparatus and laboratory methods. A method for the colorimetric determination of phosphorus. Science 100 (1944) 413-414
32. Lowry O.H., Rosebrough N.J., Farr A.L., and Randall R.J. Protein measurement with the Folin phenol reagent. J. Biol. Chem. 193 (1951) 265-275
33. Pressman B.C. Biological applications of ionophores. Ann. Rev. Biochem. 45 (1976) 501-530
34. Wallace K.B., and Starkov A.A. Mitochondrial targets of drug toxicity. Annu. Rev. Pharmacol. Toxicol. 40 (2000) 353-388
35. Regula K.M., Ens K., and Kirshenbaum L.A. Mitochondria-assisted cell suicide: a license to kill. Mol. Cell. Cardiol. J. 35 (2003) 559-567
36. Yamamoto T., and Bing R.J. Nitric oxide donors. Proc. Soc. Exp. Biol. Med. 225 (2000) 200-206
37. Rehse K., and Konig P. New NO-donors with antithrombotic and vasodilating activities, XII. Mesoionic oxatriazoles and related noncyclic nitrosohydrazine derivatives. Arch. Pharm. 328 (1995) 137-142
38. Kankaanranta H., Rydell E., Petersson A.S., Holm P., Moilanen E., Corell T., Karup G., Vuorinen P., Pedersen S.B., Wennmalm A., and Metsä-Ketelä T. Nitric oxide-donating properties of mesoionic 3-aryl substituted oxatriazole-5-imine derivatives. Br. J. Pharm. 117 (1996) 401-406
39. Khmel'nitskaya E.Yu., Levina V.I., Trukhacheva L.A., Grigoriev N.B., Kalinin V.N., Cherepanov I.A., Lebedev S.N., and Granik V.G. Sydnonimines as exogenous NO donors. Russ. Chem. Bull. 53 (2004) 2840-2844
40. Cooper C.E. Nitric oxide and cytochrome oxidase: substrate, inhibitor or effector?. Trends Biochem. Sci. 27 (2002) 33-39
41. Brookes P.S., Kraus D.W., Shiva S., Doeller J.E., Barone M.C., Patel R.P., Lancaster Jr. J.R., and Darley-Usmar V. Control of mitochondrial respiration by NO, effects of low oxygen and respiratory state. J. Biol. Chem. 278 (2003) 31603-31609
42. Brunori M., Giuffreé A., Forte E., Mastronicola D., Barone M.C., and Sarti P. Control of cytochrome c oxidase activity by nitric oxide. Biochim. Biophys. Acta 1655 (2004) 365-371
43. Borutaité V., and Brown G.C. Rapid reduction of nitric oxide by mitochondria, and reversible inhibition of mitochondrial respiration by nitric oxide. Biochem. J. 315 (1996) 295-299
44. Kraayenhof R., and Van Dam K. Interaction between uncouplers and substrates in rat liver mitochondria. Biochim. Biophys. Acta 172 (1969) 189-197
45. Susin S.A., Zamzami N., and Kroemer G. Mitochondria as regulators of apoptosis: doubt no more. Biochim. Biophys. Acta 1366 (1998) 151-165
46. Colombo P., Gunnarsson K., Iatroupoulos M., and Brughera M. Toxicological testing of cytotoxic drugs (review). Int. J. Oncol. 19 (2001) 1021-1028
47. Skulachev V.P. Why are mitochondria involved in apoptosis? Permeability transition pores and apoptosis as selective mechanisms to eliminate superoxide-producing mitochondria and cell. FEBS Lett. 397 (1996) 7-10
48. Bernardi P., Petrolini V., Di Lisa F., and Forte M.A. A mitochondrial perspective on cell death. Trends Biochem. Sci. 26 (2001) 112-117
49. Adam-Vezi V., and Chinopoulus C. Bioenergetics and the formation of mitochondrial reactive oxygen species. Trends Pharmacol. Sci. 27 (2006) 639-645